NCT07155694View on ClinicalTrials.gov

Role of Finerenone in African American Veterans With Diabetic Kidney Disease

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

August 31, 2027

Conditions

Diabetic Kidney Disease

Interventions

DRUG

Finerenone 10 MG

Take Finerenone 10 mg orally daily

DRUG

Empagliflozin 10 MG

Take Empagliflozin 10 mg orally daily for 4 months

Trial Locations (1)

20422

Washington DC Veterans Affairs Medical Center (688), Washington D.C.

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Bayer

INDUSTRY

lead

Washington D.C. Veterans Affairs Medical Center

FED